|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||0.3700 - 0.3700|
|52 Week Range||0.2110 - 0.7500|
|Beta (3Y Monthly)||-2.08|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||1.75|
RMS is a Tampa, Florida-based biomedical services company that manages Lung Health Institute, a leader in regenerative medicine specializing in cellular therapies to treat COPD and other chronic lung disorders. William “Bill” Horne, Medovex’s newly appointed CEO and a founder and former CEO of Laser Spine Institute (“LSI”) stated, “This transaction embodies our commitment to acquire and develop a diversified portfolio of innovative and disruptive healthcare solutions.
Seasoned Healthcare Industry Veteran, Founder and Former Chief Executive Officer of Laser Spine Institute to Lead Company Growth Initiative ATLANTA, Oct. 09, 2018 --.
ATLANTA, Sept. 25, 2018 -- Medovex Corp. (OTCQB:MDVX) ("Medovex" or the "Company"), the developer of the DenerveX® System, a new and novel device designed for enduring relief.